GMV 0.00% 3.9¢ g medical innovations holdings limited

Ann: GMV Granted European 'CE' Certification for 'Prizma' Case, page-42

  1. 914 Posts.
    lightbulb Created with Sketch. 301
    Admitedly sp value hasnt done our investments justice today as i believe directors have in fact, transitioned GMV from a speculative thought process:
    'What if we dont get approvals' to 2 down, one to go.
    The facts:
    We have working PRODUCTS (not prototypes).
    We have CUSTOMERS ready to pay 3/4 billion.
    We are ready to MONETISE and sell to over half the globe.
    Whats missing in this equation is a production facility and stringent QA processes, (plant rumored to be completed this month), output data, shipping, costing etc
    I dont even care about CFDA. I see tgat as inevitable. I am more interested in hearing more on factory completion because we have 2 HUGE orders waiting to be filled.
    Yakov Geva has forecast that we will be monetised by end of 2017 and we are well ahead of schedule so whats to say we dont monentise sooner rather than later.
 
watchlist Created with Sketch. Add GMV (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.